Christopher Benoit
Vorstandsvorsitzender bei Alphazyme LLC
Profil
Christopher Benoit was the founder of QIAGEN Beverly LLC, which was founded in 2006, where he held the title of Chief Commercial Officer in 2012.
Mr. Benoit is also the founder of Alphazyme LLC.
He was the Chief Executive Officer & Director at Twinstrand Biosciences, Inc. and held the title of Manager at New England Biolabs, Inc. from 1995 to 2006.
Mr. Benoit received his undergraduate degree from the University of Massachusetts.
Aktive Positionen von Christopher Benoit
Unternehmen | Position | Beginn |
---|---|---|
Alphazyme LLC
Alphazyme LLC Miscellaneous Commercial ServicesCommercial Services Part of Maravai Lifesciences Holdings, Inc., Alphazyme LLC is a company that specializes in the development and production of custom molecular biology enzymes at an industrial scale. The company is based in Jupiter, FL. The company collaborates with manufacturers of nucleic acid synthesis and detection platforms to produce high-quality and affordable enzymes for the growing markets of custom DNA and RNA molecules, genomic medicines, and genetic analysis. Alphazyme's mission is to be the world's premier partner for industrial-scale molecular biology enzymes. The company was founded by Christopher Benoit, who has been the CEO since incorporation. Alphazyme was acquired by Maravai Lifesciences Holdings, Inc. on February 22, 2023, for $145 million. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Christopher Benoit
Unternehmen | Position | Ende |
---|---|---|
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Corporate Officer/Principal | 01.01.2006 |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Vorstandsvorsitzender | - |
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Gründer | - |
Ausbildung von Christopher Benoit
University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
QIAGEN Beverly LLC
QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Health Technology |
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Process Industries |
Twinstrand Biosciences, Inc.
Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Health Technology |
Alphazyme LLC
Alphazyme LLC Miscellaneous Commercial ServicesCommercial Services Part of Maravai Lifesciences Holdings, Inc., Alphazyme LLC is a company that specializes in the development and production of custom molecular biology enzymes at an industrial scale. The company is based in Jupiter, FL. The company collaborates with manufacturers of nucleic acid synthesis and detection platforms to produce high-quality and affordable enzymes for the growing markets of custom DNA and RNA molecules, genomic medicines, and genetic analysis. Alphazyme's mission is to be the world's premier partner for industrial-scale molecular biology enzymes. The company was founded by Christopher Benoit, who has been the CEO since incorporation. Alphazyme was acquired by Maravai Lifesciences Holdings, Inc. on February 22, 2023, for $145 million. | Commercial Services |